Pharmacology News and Research

Latest Pharmacology News and Research

ACS Chemical Biology report supports zebrafish for drug development

By combining the tools of medicinal chemistry and zebrafish biology, a team of Vanderbilt investigators has identified compounds that may offer therapeutic leads for bone-related diseases and cancer.

22 Jan 2010

DIA Annual EuroMeeting programme in Monaco

The Drug Information Association (DIA) in Europe will host its 22nd Annual EuroMeeting from 8-10 March 2010 in Monaco. The DIA Annual EuroMeeting features more than 110 hot-topic sessions across 13 themes and attracts more than 3,000 professionals from the biopharmaceutical industry, contract service organisations, regulatory agencies, health ministries and academia, as well as patients and students worldwide.

22 Jan 2010

MDRNA to receive European patent for its intranasal insulin formulation

MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that the European Patent Office intends to grant a patent for application EP06826368 covering formulations for the intranasal delivery of rapid acting insulin, and its use for the treatment of diabetes.

21 Jan 2010

ABC publishes Pycnogenol monograph

The nonprofit American Botanical Council (ABC) has just published a monograph summarizing selected scientific and clinical studies of Pycnogenol®, a patented dietary ingredient from French maritime pine bark.

21 Jan 2010

Mirror therapy before amputation may prevent phantom limb pain

A simple technique called mirror therapy seems effective in preventing phantom limb pain in patients undergoing amputation of an arm or leg, suggests a study in the February 2010 issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

21 Jan 2010

SCA begins new initiative to make 'error-free' cardiac surgery a reality

Is it possible for cardiac surgery teams to completely eliminate medical errors? That's the goal of an ambitious project—called the "Flawless Operative Cardiovascular Unified Systems" (FOCUS) initiative—being undertaken by the Society of Cardiovascular Anesthesiologists (SCA).

21 Jan 2010

Kolltan Pharmaceuticals raises $10M for advancing its therapeutic development pipeline

Kolltan Pharmaceuticals, Inc., a next-generation oncology therapeutics company, announced today that it has raised $10 million in investments and related payments from an affiliate of Celtic Therapeutics Holdings L.P. (“Celtic Therapeutics”) and Tichenor Ventures, LLC.

20 Jan 2010

Researchers measure medical students' attitudes and beliefs about CAM

In the largest national survey of its kind, researchers from UCLA and UC San Diego measured medical students' attitudes and beliefs about complementary and alternative medicine (CAM) and found that three-quarters of them felt conventional Western medicine would benefit by integrating more CAM therapies and ideas.

20 Jan 2010

HSF1A stimulates more protein chaperones and reduces protein misfolding

Scientists at Duke University Medical Center have found some compounds that improve a cell's ability to properly "fold" proteins and could lead to promising drugs for degenerative nerve diseases, including Huntington's disease, Alzheimer's disease and Parkinson's disease.

20 Jan 2010

Zeshaan A. Rasheed receives the 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Zeshaan A. Rasheed, M.D., Ph.D., the 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant.

20 Jan 2010

Repeated exposure to tobacco smoke makes lung cancer much worse

Repeated exposure to tobacco smoke makes lung cancer much worse, and one reason is that it steps up inflammation in the lung. Scientists at the University of California, San Diego School of Medicine have found that mice with early lung cancer lesions that were repeatedly exposed to tobacco smoke developed larger tumors - and developed tumors more quickly - than unexposed animals.

19 Jan 2010

Scientists launch NEWMEDS project to develop drugs for schizophrenia and depression

An international consortium of scientists, led by H. Lundbeck A/S and King's College London, has launched one of the largest ever research academic-industry collaboration projects to find new methods for the development of drugs for schizophrenia and depression.

19 Jan 2010

Study reveals link between serotonin receptor number and antidepressant treatment

An excess of one type of serotonin receptor in the center of the brain may explain why antidepressants fail to relieve symptoms of depression for 50 percent of patients, a new study from researchers at Columbia University Medical Center shows.

18 Jan 2010

A comprehensive overview of stress from neurolobiological and immunological perspective

Stress is one of the most frequently used 'buzz words' across Western societies with an array of meanings ranging from scientifically defined experimental conditions for laboratory animals to a casual word for a nuisance.

18 Jan 2010

Researchers discover how cells flatten out as they adhere to internal bodily surfaces

Researchers at the University of Illinois at Chicago College of Medicine have discovered how cells in the body flatten out as they adhere to internal bodily surfaces, the first step in a wide range of important processes including clot formation, immune defense, wound healing, and the spread of cancer cells.

18 Jan 2010

Medpace acquires Medical Consulting Dr. Schlichtiger

Medpace, a privately held, global, full-service clinical research organization, is pleased to announce that it has acquired Medical Consulting Dr. Schlichtiger GmbH, a European CRO with extensive drug development expertise providing customized regulatory and pharmacovigilance services to pharmaceutical, biotechnology and nutritional companies of all sizes based in Munich, Germany.

18 Jan 2010

Findings could pave way for new therapeutic approaches for Friedreich's ataxia

Elevated levels of DNA damage have for the first time been found in the cellular mitochondria and nuclei of patients with the inherited, progressive nervous system disease called Friedreich's ataxia (FRDA), says a multicenter research team led by an expert from the University of Pittsburgh Cancer Institute (UPCI).

18 Jan 2010

Dartmouth researchers to develop and market a drug throughout Asia for treatment of CKD

Thanks in part to more than a decade of preclinical work by Dartmouth researchers, a Japanese biopharmaceutical firm is preparing to develop and market throughout Asia a drug for the treatment of chronic kidney disease (CKD).

18 Jan 2010

AVIR Green Hills Biotechnology commences deltaFLU Phase II study

AVIR Green Hills Biotechnology, the innovative biotech company based in Vienna, has started the New Year by embarking on the first clinical phase II study for the seasonal vaccine deltaFLU. The study will be carried out at the Medical University of Vienna. With this step, AVIR Green Hills has set yet another important milestone in the development of effective and modern influenza vaccines.

18 Jan 2010

Olfactory dysfunction may serve as an early diagnostic tool for Alzheimer's disease

A study published in the January 13, 2010 issue of the Journal of Neuroscience links a loss of smell function in Alzheimer's disease (AD) model animals with amyloid β (protein) accumulation in the brain, a distinguishing hallmark of Alzheimer's disease. Research conducted by NYU Langone Medical Center suggests that olfactory dysfunction, a common symptom of AD, may serve as an early diagnostic tool for the disease.

13 Jan 2010

Pharmacology News and Research

Latest Pharmacology News and Research

ACS Chemical Biology report supports zebrafish for drug development

DIA Annual EuroMeeting programme in Monaco

MDRNA to receive European patent for its intranasal insulin formulation

ABC publishes Pycnogenol monograph

Mirror therapy before amputation may prevent phantom limb pain

SCA begins new initiative to make 'error-free' cardiac surgery a reality

Kolltan Pharmaceuticals raises $10M for advancing its therapeutic development pipeline

Researchers measure medical students' attitudes and beliefs about CAM

HSF1A stimulates more protein chaperones and reduces protein misfolding

Zeshaan A. Rasheed receives the 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant

Repeated exposure to tobacco smoke makes lung cancer much worse

Scientists launch NEWMEDS project to develop drugs for schizophrenia and depression

Study reveals link between serotonin receptor number and antidepressant treatment

A comprehensive overview of stress from neurolobiological and immunological perspective

Researchers discover how cells flatten out as they adhere to internal bodily surfaces

Medpace acquires Medical Consulting Dr. Schlichtiger

Findings could pave way for new therapeutic approaches for Friedreich's ataxia

Dartmouth researchers to develop and market a drug throughout Asia for treatment of CKD

AVIR Green Hills Biotechnology commences deltaFLU Phase II study

Olfactory dysfunction may serve as an early diagnostic tool for Alzheimer's disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Pharmacology News and Research

Latest Pharmacology News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in